Fingerprint
Dive into the research topics of 'Adverse events of concurrent radiotherapy and ALK inhibitors for brain metastases of ALK-rearranged lung adenocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Adverse events of concurrent radiotherapy and ALK inhibitors for brain metastases of ALK-rearranged lung adenocarcinoma
Takaaki Nakashima, Takeshi Nonoshita, Hidenari Hirata, Kouji Inoue, Akira Nagashima, Tadamasa Yoshitake, Kaori Asai, Yoshiyuki Shioyama
Research output: Contribution to journal › Article › peer-review
3
Citations
(Scopus)